A Comparison of Diagnostic Approaches for Malaria and Pneumonia
NCT ID: NCT02482116
Last Updated: 2016-08-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1000 participants
OBSERVATIONAL
2015-08-31
2017-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Can Treatment of Malaria be Restricted to Parasitologically Confirmed Malaria?
NCT00913146
Malaria Rapid Diagnostic Tests (RDTs) in Pregnancy: Detection of Placental Malaria
NCT01555255
Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, Mali
NCT01168271
Home Management of Malaria and Pneumonia
NCT02151578
Rapid Diagnostic Tests (RDTs) for Malaria in Kampala, Uganda
NCT00327964
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The research will compare the accuracy of these various diagnostic approaches using measures such as sensitivity, specificity, positive predictive value, negative predictive value, and area under the receiver operating characteristic curve. The research will also assess patient outcomes like complications, hospitalisation and death following a diagnosis of either pneumonia or malaria in all study participants as well as costs associated with malaria and pneumonia.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
malaria or pneumonia diagnosis
Diagnostic approaches for malaria (lay diagnosis, as per IMCI guidelines by trained primary healthcare workers, clinical diagnosis by medically qualified doctor, rapid diagnostic tests, Giemsa microscopy); Diagnostic approaches for pneumonia (lay diagnosis, as per IMCI guidelines by trained primary healthcare workers, clinical diagnosis by medically qualified doctor, chest x-ray)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Suspected pneumonia (fever, cough, shortness of breath/difficulty in breathing, with or without chills and no other probable diagnosis)
* Willingness of caregiver to provide written or verbal consent in the presence of a witness.
Exclusion Criteria
2 Months
4 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Benin
OTHER
University of Nottingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kelly O Elimian, MSc
Role: PRINCIPAL_INVESTIGATOR
University of Nottingham & University of Benin
Puja R Myles, PhD
Role: STUDY_DIRECTOR
University of Nottingham
Catherine Pritchard, PhD
Role: STUDY_DIRECTOR
University of Nottingham
Ayebo Sadoh, PhD
Role: STUDY_DIRECTOR
University of Benin
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Health Services Department, University of Benin
Benin City, Edo, Nigeria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HA.577/Vol. II/126
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.